Betterthangold
:
$10.76 was the all time low. This may be one of the Best Buy’s of the year. The company is solid, they’ll perfect their viral, ingestible treatment as they’re continuing clinical studies. The stock has seen a high of over $94 this year, has an average cost around $24 & had, IMO an overreaction to thIs last round of trials where the ingestible treatment did not affect severe cases of C-19. The value is still there and has been before C-19. I’m excited to get in at such a low price. This isn’t a meme stock, squeeze play. I see a 100-200% increase over the next couple of months.
john wee : Don't walk too low, your feet will get sour hahahaha![joy 😂](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f602.png)
jjsteo OP john wee : Look at it, it hurts my feet. My heart is exhausted.![joy 😂](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f602.png)
![joy 😂](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f602.png)
![joy 😂](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f602.png)
john wee : hahaha right
jjsteo OP john wee : Can be shared. How much did you buy? How many shares bought?
john wee : I bought less. When I bought it, it was $14.88
john wee : My feet are soft now hahaha
jjsteo OP john wee : I'm soft too. $15.4![face_exhaling 😮💨](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62e-200d-1f4a8.png)
![face_exhaling 😮💨](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62e-200d-1f4a8.png)
![face_exhaling 😮💨](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62e-200d-1f4a8.png)
![face_exhaling 😮💨](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62e-200d-1f4a8.png)
john wee jjsteo OP : Wow, you've lost quite a bit too. Let's all go for it; we need him to take a little longer haha
jjsteo OP john wee : I just have to keep it and wait for it to go back.
Betterthangold : $10.76 was the all time low. This may be one of the Best Buy’s of the year. The company is solid, they’ll perfect their viral, ingestible treatment as they’re continuing clinical studies. The stock has seen a high of over $94 this year, has an average cost around $24 & had, IMO an overreaction to thIs last round of trials where the ingestible treatment did not affect severe cases of C-19. The value is still there and has been before C-19. I’m excited to get in at such a low price. This isn’t a meme stock, squeeze play. I see a 100-200% increase over the next couple of months.
View more comments...